BLRX

BioLineRX

16 hedge funds and large institutions have $8.21M invested in BioLineRX in 2014 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 3 closing their positions.

Holders
16
Holders Change
-2
Holders Change %
-11.11%
% of All Funds
0.46%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
5
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
SM
1
Senvest Management
New York
$2.46M 1,596,367 +5,000 +0.3%
BI
2
BVF Inc
California
$2.31M 1,501,000
O
3
OrbiMed
New York
$1.75M 1,135,000
OM
4
Opaleye Management
Massachusetts
$755K 490,000 -160,000 -25%
SFM
5
Sphera Funds Management
Israel
$298K 193,284 -406,716 -68%
Deutsche Bank
6
Deutsche Bank
Germany
$295K 191,850
Renaissance Technologies
7
Renaissance Technologies
New York
$197K 128,100 +84,400 +193%
BCA
8
Benchmark Capital Advisors
New York
$62K 40,000
NFG
9
Next Financial Group
Texas
$30K 19,500 +2,000 +11%
Bank of New York Mellon
10
Bank of New York Mellon
New York
$27K 17,800
Morgan Stanley
11
Morgan Stanley
New York
$16K 10,275
TRCT
12
Tower Research Capital (TRC)
New York
$7K 4,326 +4,326 New
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$3K 2,000 -10,000 -83%
Wells Fargo
14
Wells Fargo
California
$2K 1,000
U
15
UBS
Switzerland
$1K 624 -9,376 -94%
SM
16
Sabby Management
Florida
-2,021,347 Closed
PA
17
Perceptive Advisors
New York
-165,698 Closed
VKH
18
Virtu KCG Holdings
New York
-11,962 Closed
Ameriprise
19
Ameriprise
Minnesota
$0 291 -19 -6%